Type 2 diabetes mellitus patients were treated with anti-diabetic drugs and/or insulin in 61.6% of cases and lipid-lowering drugs were taken by 35.2% of diabetes patients and 23.8% of NOGTT subjects. This evidence concerns the gene INS and diabetes mellitus.